Geoffrey M. Parker's Restricted Stock Unit Vesting at Allogene Therapeutics, Inc.

On October 21, 2025, Geoffrey M. Parker, an officer at Allogene Therapeutics, Inc., reported the vesting of 36,744 restricted stock units (RSUs) in the company's common stock. The RSUs were granted as part of the issuer's equity compensation plan and vested on October 20, 2025. The aggregate market value of the vested shares was approximately $46,168.98. Parker did not report any securities sold in the past three months. The transaction was facilitated through Morgan Stanley Smith Barney LLC Executive Financial Services. This filing is a Form 144, which is used to report the proposed sale of securities under Rule 144 of the Securities Act of 1933.